Coach for High-Content Imaging
My name is
Stefan Prechtl
I am a passionate scientist and an expert in High-Content Imaging. With over 20 years of experience in pharmaceutical research, I provide clients with the knowledge they need to effectively utilize advanced technologies for HCI in early research laboratories.
Stefan Prechtl
Proven Track Record in Advanced Drug Discovery
Decades of hands-on expertise in HCI has driven substantial advancements in early pharma research and chemical optimization.
Commitment to Scientific Excellence
Drives the refinement of imaging techniques and research outcomes, keeping teams at the forefront of HCI and drug discovery.
Global Recognition And Collaborative Spirit
Renowned for combining technical expertise with excellent communication and interpersonal skills, enabling strong partnerships.
Innovative Approach to Imaging
Integrates advanced HCI-related technologies into effective research workflows to ensure teams stay at the forefront of the industry.
My Core Services Are
Drive innovation in your early drug discovery and cell biology research with my customized coaching services for your High-Content Imaging efforts.
Strategic Advising
Streamline your work processes to maximize the efficiency of your experiments and improve your results
Technology Scouting
Stay ahead of the technology curve. Identify, implement, and benefit from the latest advanced scientific tools.
Partnering Services
Establish effective collaborations to expand your research capabilities and transform challenges into opportunities.
Service Packages at a Glance
Starter Science
Small business and startups
Grow Science
Medium-sized enterprises
Scale Science
Large enterprises & corporations
Tailored Science
Companies with specific requirements
Problem
In the early stages of drug discovery, research teams often struggle with developing reliable cellular assays and ensuring the quality of high-throughput screening (HTS) data. These challenges can lead to delays, inefficiencies, and uncertainties in the identification of viable targets and compounds.
Solution
Stefan brings over 25 years of experience in High-Content Screening and cellular assays, having been involved in the field since its inception. His hands-on expertise in developing hundreds of assays and conducting HTS campaigns provides research teams with critical insights into target biology and screen quality. These insights enable teams to streamline their workflows, improve data reliability, and make informed decisions faster.
Stefan’s unmatched experience in live assay data provides insights into target and screen quality that are simply invaluable
Mike Snider
Former Director of Molecular Pharmacology at Berlex Biosciences
Problem
The company recognized the need to enhance their imaging skills and improve their ability to deliver high-quality results in advanced cellular models. There was also a desire to continue receiving positive feedback from customers by refining their techniques and knowledge in imaging.
Solution
Stefan led a three-day imaging workshop that delivered expert insights, best practices, and valuable tips for improving imaging in advanced cellular models. The workshop significantly enhanced participants' skills, reinforcing Axxam's commitment to scientific excellence and ensuring continued customer satisfaction.
Stefan led an unparalleled imaging workshop that provided an invaluable opportunity to perfect our imaging skills and stay at the cutting edge of industry best practices.
Fernanda Ricci, PhD
Molecular Biophysicist (PhD) | High Content Screening - Unit Manager | Passionate about Technology Transfer & Innovation
Problem
In our early pharmaceutical research and preclinical development, finding effective high-content imaging and screening methods was a major challenge. The need to evaluate innovative imaging approaches, manage interdisciplinary projects, and communicate complex scientific concepts to diverse audiences made progress difficult.
Solution
With Stefan’s expertise, these challenges were tackled with precision and efficiency. Cutting-edge imaging strategies were carefully selected and implemented, leading to remarkable success. He skillfully managed complex R&D projects and delivered outstanding results even under tight deadlines.
Stefan’s extensive expertise in evaluating and selecting innovative high-content imaging approaches has been instrumental in advancing our drug discovery projects to the next level.
Dr. Anke Müller-Fahrnow
VP, Senior Advisor Innovation Campus Berlin
Problem
Our team recognized the need to take our imaging skills to the next level to deliver even higher-quality results with advanced cellular models. At the same time, we wanted to maintain and enhance the positive feedback we were receiving from our customers by refining our techniques and deepening our knowledge in imaging.
Solution
Stefan organized and led a three-day imaging workshop tailored to our needs. He shared expert insights, practical tips, and best practices that helped us significantly improve our imaging capabilities. The workshop not only enhanced our technical skills but also reinforced Axxam’s dedication to scientific excellence, enabling us to maintain our high customer satisfaction standards.
Stefan’s extensive expertise in evaluating and selecting innovative high-content imaging approaches has been instrumental in advancing our drug discovery projects to the next level.
Andrea Faedo
Head of Molecular and Cellular Biology Group
Get in touch with me anytime and let's get to know each other.
Let's talk through your concerns and find an efficient and time-saving solution for you.
Frequently Asked Questions (FAQ)
What are the benefits of High-Content Imaging in early research?
High-Content Imaging allows for detailed analysis of cell morphology and physiological processes in a high-throughput format, which speeds up the identification of drug candidates and the understanding of cellular mechanisms.
How can your consulting services support our HCI project?
My services provide comprehensive support in selecting and implementing the right HCI technologies, developing experimental designs, and analyzing image data to maximize the efficiency and accuracy of your research projects.
What experience do you have with implementing HCI in pharmaceutical research?
I have more than two decades of experience implementing advanced HCI technologies in early drug discovery, including assay automation, assay miniaturization, 3D cell modeling, ML-based image analysis, and integration of HCI data with other research results.
What types of projects have you successfully completed?
I've successfully completed projects in areas as diverse as cancer research, drug discovery and functional genomics, fungicide research, and plant growth research using HCI to analyze cell and whole organism phenotypes on a large scale.
How long does it typically take to implement an HCI project?
The timeline depends on the complexity of the project, but typically, implementing and optimizing an HCI project can take anywhere from a few weeks to several months.
What are the costs associated with implementing HCI?
Costs vary depending on the scope of the project, the hardware and software required, and data analysis needs. We offer tailored quotes based on the specific requirements of your project.
Can you assist with data analysis and interpretation?
Yes, I have extensive experience in analyzing HCI data, including using image analysis software, statistical evaluation, and machine learning to interpret the results.
What software and technologies do you recommend for HCI projects?
I recommend proven HCI platforms from commercial vendors and custom image analysis pipelines from renowned academic institutions. Please call me if you are interested in detailed information.
How do you ensure the quality and reproducibility of HCI data?
By using standardized protocols, rigorous quality assurance measures, and partnering with experienced technology providers, you can ensure the data collected is robust and reproducible.
How can HCI be combined with other technologies to enhance research?
HCI can be integrated with other technologies like transcriptomics, proteomics, and CRISPR screens to gain deeper insights into cellular processes and achieve synergistic effects that enhance research outcomes.
This website is not part of the Facebook website or Facebook Inc. Furthermore, this website is in no way endorsed by Facebook. Facebook is a brand of Facebook, Inc. We use Google remarketing pixels/cookies on this website to re-communicate with visitors to our website and ensure that we can reach them with relevant messages and information in the future. Google places our ads on third party websites on the internet to communicate our message and reach the right people who have shown interest in our information in the past.